Vertex Pharmaceuticals (VRTX) Non Operating Income (2016 - 2025)
Historic Non Operating Income for Vertex Pharmaceuticals (VRTX) over the last 14 years, with Q3 2025 value amounting to -$9.8 million.
- Vertex Pharmaceuticals' Non Operating Income rose 4201.18% to -$9.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$29.1 million, marking a year-over-year increase of 6407.41%. This contributed to the annual value of -$86.1 million for FY2024, which is 27763.16% down from last year.
- According to the latest figures from Q3 2025, Vertex Pharmaceuticals' Non Operating Income is -$9.8 million, which was up 4201.18% from $13.2 million recorded in Q2 2025.
- Vertex Pharmaceuticals' 5-year Non Operating Income high stood at $42.4 million for Q3 2021, and its period low was -$78.1 million during Q2 2022.
- In the last 5 years, Vertex Pharmaceuticals' Non Operating Income had a median value of -$14.9 million in 2024 and averaged -$14.9 million.
- In the last 5 years, Vertex Pharmaceuticals' Non Operating Income tumbled by 250000.0% in 2024 and then surged by 15714.29% in 2025.
- Quarter analysis of 5 years shows Vertex Pharmaceuticals' Non Operating Income stood at $7.1 million in 2021, then tumbled by 538.03% to -$31.1 million in 2022, then surged by 68.49% to -$9.8 million in 2023, then crashed by 52.04% to -$14.9 million in 2024, then soared by 34.23% to -$9.8 million in 2025.
- Its last three reported values are -$9.8 million in Q3 2025, $13.2 million for Q2 2025, and -$17.6 million during Q1 2025.